PPGN.SW Stock Analysis
PP
Uncovered
PolyPeptide Group AG is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
0/100
Low score
PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Baar, Zug and currently employs 1,139 full-time employees. The company went IPO on 2021-04-29.
View Section: Eyestock Rating